RAD. My last add was $5.58, 3/3/04, so I don't look so good if you go by that.
If RAD is down because of "mandatory mail-order prescription refill programs" as they (RAD) say, then we've got a problem because the business model has shifted (imo). The extent of this and whether or not RAD can adapt (if this situation does exist and if RAD fully recognize it), is questionable (for me) at this point. OTOH, Motley Fool says Walgreen and perhaps CVS will/are reporting much better than Rite Aid, "the tortoise in the bunch". If so, that's good news - to me anyway - because I am just looking for RAD -the number three in the sector - to eventually get its fair share of the business. To the extent that WAG and CVX are doing okay and might continue to do so, means -to me- that RAD might also have good quarters ahead of it. In which case I might add more shares. But back on that other hand, the more that "customers" are forced by their insurance carriers to purchase mail order, the stiffer the consequence for the brick retailers/prescription fillers like RAD. In which case, maybe all the companies - WAG,etc. - are too richly valued.
For now, I've no strong opinion, so I figure I'll just hold my RAD position. Anyone else - Larry S.?? - still here following this company with an opinion to share? |
